Navigation Links
MedCath Corporation to Present at the Raymond James & Associates 30th Annual Institutional Investors Conference

CHARLOTTE, N.C., March 3 /PRNewswire-FirstCall/ -- MedCath Corporation (Nasdaq: MDTH) announced that its senior management will give a presentation at the Raymond James & Associates 30th Annual Institutional Investors Conference held March 8-11 at the JW Marriott Grande Lakes in Orlando, Florida.

MedCath's senior management will give its presentation on Tuesday, March 10 at 1:40 pm Eastern time. The presentation will be web cast live over the Internet via MedCath's website ( and will be available for 30 days.

MedCath Corporation, headquartered in Charlotte, N.C., is a healthcare provider focused on high acuity services with the diagnosis and treatment of cardiovascular disease being a primary service offering. MedCath owns an interest in and operates nine hospitals with a total of 676 licensed beds, located in Arizona, Arkansas, California, Louisiana, New Mexico, South Dakota, and Texas. MedCath is in the process of developing its tenth hospital, which is anticipated to open in fall 2009, in Kingman, Ariz. In addition, MedCath and its subsidiary MedCath Partners provide services in diagnostic and therapeutic facilities in various states.

SOURCE MedCath Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. MedCath Corporation Reports First Quarter Earnings
2. MedCath Corporation to Hold Conference Call on First Quarter Results
3. MedCath Corporation Announces Completion of Sale of Equity Interest in Joint Venture
4. MedCath Corporation to Hold Conference Call on Fourth Quarter Results
5. MedCath Corporation Reports Third Quarter Earnings
6. MedCath Announces Completion of Sale of Dayton Heart Hospital to Good Samaritan Hospital-Dayton
7. MedCath Names Parker to New Finance Post
8. MedCath Corporation to Present at the Banc of America Securities 2008 Health Care Conference
9. MedCath Corporation Reports Second Quarter Earnings
10. MedCath Corporation to Present at the Deutsche Bank Securities 33rd Annual Health Care Conference
11. MedCath Provides Preliminary Second Quarter Fiscal 2008 Earnings and Updates Fiscal 2008 Outlook
Post Your Comments:
(Date:6/25/2016)... Oklahoma (PRWEB) , ... June 25, 2016 , ... ... both athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures ... Oklahoma City area —Johnson is one of the first doctors to perform the ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic ... many turn to unhealthy avenues, such as drug or alcohol abuse, as a coping ... released tools for healthy coping following a traumatic event. , Trauma sufferers tend to ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Global law ... magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this recognition are ... , Seven Greenberg Traurig Shareholders received special honors as members of this year’s Legal ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are sharpening their pencils ... an essay contest in which patients and their families pay tribute to a genetic ... 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... feeding the Frederick area economy by obtaining investment capital for emerging technology companies. ... 2½ years that have already resulted in more than a million dollars of ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016  Arkis BioSciences, a ... invasive and more durable cerebrospinal fluid treatments, today ... The Series-A funding is led by Innova Memphis, ... and other private investors.  Arkis, new financing will ... and the market release of its in-licensed Endexo® ...
(Date:6/23/2016)... BEVERLY HILLS, Calif. , June 23, 2016 ... faced the many challenges of the current process. Many of ... option because of the technical difficulties and high laboratory costs ... would have to offer it at such a high cost ... to afford it. Dr. Parsa Zadeh , ...
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced ... BRAHMS PCT (procalcitonin) assay as a dedicated testing solution ... this clearance, Roche is the first IVD company in ... sepsis risk assessment and management. PCT is ... levels in blood can aid clinicians in assessing the ...
Breaking Medicine Technology: